Difference between revisions of "Enzalutamide"

From Libre Pathology
Jump to navigation Jump to search
(Created page with "'''Enzalutamide''' is an antrogen receptor antagonist used to treat prostate cancer.<ref name=pmid23887973>{{Cite journal | last1 = Mitsiades | first1 = N. | title = A ro...")
 
Line 8: Line 8:


[[Category:Clinical]]
[[Category:Clinical]]
[[Category:Drugs]]

Revision as of 14:51, 30 May 2016

Enzalutamide is an antrogen receptor antagonist used to treat prostate cancer.[1]

See also

References

  1. Mitsiades, N. (Aug 2013). "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.". Cancer Res 73 (15): 4599-605. doi:10.1158/0008-5472.CAN-12-4414. PMID 23887973.